Elisha W. Finney Sells 76 Shares of Mettler-Toledo International Inc. (NYSE:MTD) Stock

Mettler-Toledo International Inc. (NYSE:MTD) Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares of the company’s stock, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock opened at $1,239.13 on Friday. Mettler-Toledo International Inc. has a 52 week low of $1,039.01 and a 52 week high of $1,546.93. The stock has a 50 day moving average price of $1,388.91 and a two-hundred day moving average price of $1,401.80. The stock has a market capitalization of $26.15 billion, a PE ratio of 33.41, a price-to-earnings-growth ratio of 4.16 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Research analysts forecast that Mettler-Toledo International Inc. will post 40.37 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on MTD shares. JPMorgan Chase & Co. raised their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Evercore ISI raised their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Wells Fargo & Company decreased their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday. Finally, Robert W. Baird decreased their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,338.75.

Institutional Trading of Mettler-Toledo International

Hedge funds have recently bought and sold shares of the business. Family Firm Inc. bought a new stake in Mettler-Toledo International during the second quarter worth $25,000. Blue Trust Inc. lifted its holdings in Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares during the period. Ashton Thomas Securities LLC bought a new stake in Mettler-Toledo International during the third quarter worth $37,000. Rothschild Investment LLC bought a new stake in Mettler-Toledo International during the second quarter worth $42,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Mettler-Toledo International during the second quarter worth $42,000. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.